* Announces that the first implantation of its bioprosthetic
artificial heart within the framework of the pivotal study has
been carried out in accordance with the authorizations obtained
from the ANSM (French national agency for the safety of
medicines and health products) and CPP (patient protection
committee)
Read more
No comments:
Post a Comment